See also this year's filing and all EDGAR filings for this company.
PDF Report 0001784440_2026_Bioscience_Health_Innovations_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.08003593245474494, 'aggregate_val': 1707181, 'exp_sum': 1855704, 'exp_to_value': {'AssetsCurrent': 1558658, 'AssetsNonCurrent': 148523, 'IntangibleAssets': 82887, 'remainder_Assets': 65636}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001784440, Bioscience Health Innovations Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,558,658 |
| 1 | AssetsNonCurrent | 148,523 |
| 2 | IntangibleAssets | 82,887 |
| 3 | remainder_Assets | -82,887 |
| 4 | LiabilitiesCurrent | 0 |
| 5 | LiabilitiesNonCurrent | 0 |
| 6 | remainder_Liabilities | 229,851 |
| 7 | CostOfGoodsAndServicesSold | 2,448,000 |
| 8 | SellingExpense | 2,206,495 |
| 9 | GeneralAndAdministrativeExpense | 0 |
| 10 | ResearchAndDevelopment | 0 |
| 11 | DepreciationDepletionAndAmortization | 0 |
| 12 | remainder_Expenses | 392,132 |
| 13 | remainder_Revenues | 5,688,717 |
| 14 | remainder_NetIncome | 0 |
| 15 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,707,181 |
| 1 | Liabilities | 229,851 |
| 2 | Expenses | 5,046,627 |
| 3 | Revenues | 5,688,717 |
| 4 | StockholdersEquity | 1,477,330 |
| 5 | NetIncome | 642,090 |
| 6 | ComprehensiveNetIncome | 642,090 |
| 7 | BaseVar | 9,020,024 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.30 |
| 9 | EconomicCapitalRatio | 4.06 |
Edgar->Model Mapping
Feature Distribution
Change over Time
